Toxicology in the critical care unit

Chest

Volumn 133, Issue 4, 2008, Pages 1006-1013

  Alapat, Philip M ^b   Zimmerman, Janice L ^a,c  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Alcohols; Analgesics; Antidepressants; Antipsychotics; Carbon monoxide; Methemoglobinemia; Overdose; Propofol

Indexed keywords

ACETYLCYSTEINE; ACTIVATED CARBON; ALCOHOL; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BUPRENORPHINE; CARBAMAZEPINE; CARBON MONOXIDE; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; DAPSONE; FENTANYL; HYPNOTIC SEDATIVE AGENT; ILLICIT DRUG; IPECAC; LAXATIVE; LITHIUM; NALOXONE; NEUROLEPTIC AGENT; PARACETAMOL; PHENOBARBITAL; PROPOFOL; PROPYLENE GLYCOL; QUININE; SALICYLIC ACID; THEOPHYLLINE; TOXIN; TRAMADOL; UNINDEXED DRUG; VALPROIC ACID;

ALCOHOL INTOXICATION; CARBON MONOXIDE INTOXICATION; CRITICALLY ILL PATIENT; DRUG INTOXICATION; HUMAN; INTENSIVE CARE UNIT; LOADING DRUG DOSE; METHEMOGLOBINEMIA; PRIORITY JOURNAL; REVIEW;

EID: 42149090454     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1840     Document Type: Article

References (84)

1. Betten DP, Vohra RB, Cook MD, et al. Antidote use in the critically ill poisoned patient. J Intensive Care Med 2006; 21:255-277
2. Mokhlesi B, Leikin JB, Murray P, et al. Adult toxicology in critical care: part II: specific poisonings. Chest 2003; 123:897-922
3. Mokhlesi B, Leiken JB, Murray P, et al. Adult toxicology in critical care: part I: general approach to the intoxicated patient. Chest 2003; 123:577-592
4. Zimmerman JL. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 2003; 31:2794-2801
5. von Mach MA, Weber C, Meyer MR, et al. Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department. Ther Drug Monit 2007; 29:27-39
6. Montague RE, Grace RF, Lewis JH, et al. Urine drug screens in overdose patients do not contribute to immediate clinical management. Ther Drug Monit 2001; 23:47-50
7. Chyka PA, Seger D, Krenzelok EP, et al. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43:61-87
8. Position paper: cathartics. J Toxicol Clin Toxicol 2004; 42:243-253
9. Position paper: ipecac syrup. J Toxicol Clin Toxicol 2004; 42:133-143
10. Vale JA, Kulig K. Position paper: gastric lavage. J Toxicol Clin Toxicol 2004; 42:933-943
11. Position paper: whole bowel irrigation: J Toxicol Clin Toxicol 2004; 42:843-854
12. Proudfoot AT, Krenzelok EP, Vale JA. Position paper on urine alkalinization. J Toxicol Clin Toxicol 2004; 42:1-26
13. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1999; 37:731-751
14. Goldfarb DS, Matalon D. Principles and techniques applied to enhance elimination. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicologic emergencies, 8th ed. New York, NY: McGraw Hill, 2006
15. Goodman JW, Goldfarb DS. The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial 2006; 19:402-407
16. Lai MW, Klein-Schwartz W, Rodgers GC, et al. 2005 annual report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila) 2006; 44:803-932
17. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975; 55:871-876
18. Bond GR, Hite LK. Population-based incidence and outcome of acetaminophen poisoning by type of ingestion. Acad Emerg Med 1999; 6:1115-1120
19. Cetaruk EW, Dart RC, Hurlbut KM, et al. Tylenol extended relief overdose. Ann Emerg Med 1997; 30:104-108
20. Brok J, Buckley N, Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev 2006; 2:CD003328
21. Kanter MZ. Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 2006; 63:1821-1827
22. Kerr F, Dawson A, Whyte IM, et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005; 45:402-408
23. Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's toxicologic emergencies, 8th ed. New York, NY: McGraw Hill, 2006
24. Daly FF, O'Malley GF, Heard K, et al. Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med 2004; 44:393-398
25. Buckley NA, Whyte IM, O'Connell DL, et al. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol 1999; 37:753-757
26. Spiller HA, Sawyer TS. Impact of activated charcoal after acute acetaminophen overdoses treated with N-acetylcysteine. J Emerg Med 2007; 33:141-144
27. Spiller HA, Krenzelok EP, Grande GA, et al. A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose. Ann Emerg Med 1994; 23:519-523
28. Rowden AK, Norvell J, Eldridge DL, et al. Updates on acetaminophen toxicity. Med Clin North Am 2005; 89:1145-1159
29. Bernal W, Wendon J, Rela M, et al. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27:1050-1055
30. van Dorp E, Yassen A, Sarton E, et al. Naloxone reversal of buprenorphine-induced respiratory depression. Anesthesiology 2006; 105:51-57
31. Tjaderborn M, Jonsson AK, Hagg S, et al. Fatal unintentional intoxications with tramadol during 1995-2005. Forensic Sci Int 2007; 173:107-111
32. Jovanovic-Cupic V, Martinovic Z, Nesic N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol (Phila) 2006; 44:143-146
33. Martin TL, Woodall KL, McLellan BA. Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004). J Anal Toxicol 2006; 30:603-610
34. Kuhlman JJ Jr, McCaulley R, Valouch TJ, et al. Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J Anal Toxicol 2003; 27:499-504
35. Hoiseth G, Bramness JG, Christophersen AS, et al. Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003. Int J Legal Med 2006
36. Isbister GK, O'Regan L, Sibbritt D, et al. Alprazolam is relatively more toxic than other benzodiazepines in overdose. Br J Clin Pharmacol 2004; 58:88-95
37. Ngo AS, Anthony CR, Samuel M, et al. Should a benzodiazepine antagonist be used in unconscious patients presenting to the emergency department? Resuscitation 2007; 74:27-37
38. Seger DL. Flumazenil: treatment or toxin. J Toxicol Clin Toxicol 2004; 42:209-216
39. McKenzie MS, McFarland BH. Trends in antidepressant overdoses. Pharmacoepidemiol Drug Saf 2007; 16:513-523
40. Bradberry SM, Thanacoody HK, Watt BE, et al. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate. Toxicol Rev 2005; 24:195-204
41. McCabe JL, Cobaugh DJ, Menegazzi JJ, et al. Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate, and hyperventilation. Ann Emerg Med 1998; 32:329-333
42. McKinney PE, Rasmussen R. Reversal of severe tricyclic antidepressant-induced cardiotoxicity with intravenous hypertonic saline solution. Ann Emerg Med 2003; 42:20-24
43. Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998; 59(suppl 15):42-48
44. Evans CE, Sebastian J. Serotonin syndrome. Emerg Med J: 2007; 24:e20
45. Taylor JJ, Wilson JW, Estes LL. Linezolid and serotonergic drug interactions: a retrospective survey. Clin Infect Dis 2006; 43:180-187
46. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352:1112-1120
47. Paruchuri P, Godkar D, Anandacoomarswamy D, et al. Rare case of serotonin syndrome with therapeutic doses of paroxetine. Am J Ther 2006; 13:550-552
48. Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16:615-619
49. Varma MK, Connolly K, Fulton B. Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature. J Intensive Care Med 2007; 22:52-55
50. Kaufman KR, Levitt MJ, Schiltz JF, et al. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis. Ann Clin Psychiatry 2006; 18:201-204
51. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007; 164:870-876
52. Reulbach U, Dutsch C, Biermann T, et al. Managing an effective treatment for neuroleptic malignant syndrome. Crit Care 2007; 11:R4
53. Waring WS. Management of lithium toxicity. Toxicol Rev 2006; 25:221-230
54. Shepherd G. Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers. Am J Health Syst Pharm 2006; 63:1828-1835
55. Kanagarajan K, Marraffa JM, Bouchard NC, et al. The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose. Clin Toxicol (Phila) 2007; 45:56-59
56. Bailey B. Glucagon in β-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol Clin Toxicol 2003; 41:595-602
57. Harris NS. Case records of the Massachusetts General Hospital: case 24-2006; a 40-year-old woman with hypotension after an overdose of amlodipine. N Engl J Med 2006; 355:602-611
58. DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and β-blocker toxicity. Toxicol Rev 2004; 23:223-238
59. Yuan TH, Kerns WP, Tomaszewski CA, et al. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol 1999; 37:463-474
60. Megarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and β-blocker poisoning. Toxicol Rev 2004; 23:215-222
61. Newton CR, Delgado JH, Gomez HF. Calcium and beta receptor antagonist overdose: a review and update of pharmacological principles and management. Semin Respir Crit Care Med 2002; 23:19-25
62. White CM. A review of potential cardiovascular uses of intravenous glucagon administration. J Clin Pharmacol 1999; 39:442-447
63. Megarbane B, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med 2005; 31:189-195
64. Parsa T, Cunningham SJ, Wall SP, et al. The usefulness of urine fluorescence for suspected antifreeze ingestion in children. Am J Emerg Med 2005; 23:787-792
65. Wilson KC, Reardon C, Theodore AC, et al. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines; a case series and prospective, observational pilot study. Chest 2005; 128:1674-1681
66. Brooks DE, Wallace KL. Acute propylene glycol ingestion. J Toxicol Clin Toxicol 2002; 40:513-516
67. Emadi A, Coberly L. Intoxication of a hospitalized patient with an isopropanol-based hand sanitizer. N Engl J Med 2007; 356:530-531
68. Doyon S, Welsh C. Intoxication of a prison inmate with an ethyl alcohol-based hand sanitizer. N Engl J Med 2007; 356:529-530
69. Mokhlesi B, Garimella PS, Joffe A, et al. Street drug abuse leading to critical illness. Intensive Care Med 2004; 30:1526-1536
70. Raub JA, Mathieu-Nolf M, Hampson NB, et al. Carbon monoxide poisoning - a public health perspective. Toxicology 2000; 145:1-14
71. Juurlink DN, Buckley NA, Stanbrook MB, et al. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2005; 1:CD002041
72. Stoller KP. Hyperbaric oxygen and carbon monoxide poisoning: a critical review. Neurol Res 2007; 29:146-155
73. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002; 347:1057-1067
74. Novaro GM, Aronow HD, Militello MA, et al. Benzocaine-induced methemoglobinemia: experience from a high-volume transesophageal echocardiography laboratory. J Am Soc Echocardiogr 2003; 16:170-175
75. Moore TJ, Walsh CS, Cohen MR. Reported adverse event cases of methemoglobinemia associated with benzocaine products. Arch Intern Med 2004; 164:1192-1196
76. U.S. Food and Drug Administration Public Health Advisory. http://www.fda.gov/cder/drug/advisory/benzocaine.htm. Accessed March 5, 2008
77. Fudickar A, Bein B, Tonner PH. Propofol infusion syndrome in anaesthesia and intensive care medicine. Curr Opin Anaesthesiol 2006; 19:404-410
78. Liolios A, Guerit JM, Scholtes JL, et al. Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult. Anesth Analg 2005; 100:1804-1806
79. Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia 2007; 62:690-701
80. Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit Care Med 2006; 34:502-510
81. Buckley NA, Eddleston M, Szinicz L. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev 2005; 1:CD005085
82. Guven M, Sungur M, Eser B, et al. The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning. J Toxicol Clin Toxicol 2004; 42:617-623
83. Grmec S, Mally S, Klemen P. Glasgow coma scale score and QTc interval in the prognosis of organophosphate poisoning. Acad Emerg Med 2004; 11:925-930
84. Thomson Healthcare and Compliance. POISINDEX system. Available at: http://www.micromedex.com/products/poisindex/. Accessed March 5, 2008